Skip to content

Author

Kaori Fukuzawa

We have 4 of 23 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Identification of small-molecule inhibitors of the immune system repressor Regnase-1

Regnase-1 is an essential RNase that suppresses immune cell activation by targeting the mRNA of pro-inflammatory cytokines such as interleukin 6 (IL-6). Although genetic inhibition of Regnase-1 activity in CD8+ T cells has been shown to enhance antitumor immunity, no molecular inhibitors of Regnase-1 have been report...

Arthur Millius, C. Yew, Yuko Misumi et al. · 0 citations
Sep 2026

Upamostat potentiates bortezomib cytotoxicity and delays proteasome recovery in bortezomib-resistant malignant lymphoma cells through modulation of the DDI2/NRF1 axis.

Findings identify UMS as a candidate DDI2/NRF1-axis modulator that potentiates BTZ-induced cytotoxicity and delays functional proteasome recovery in BTZ-resistant malignant lymphoma cells.

Atsumi Ota, Sota Maruyama, Yudai Kudo et al. · 0 citations
2026

Applications of Integrated Molecular Dynamics and Fragment Molecular Orbital (MD+FMO) Calculations in Drug Discovery and Structural Biology.

This chapter summarizes current evaluation strategies using the MD+FMO approach and integration with diverse experimental techniques, highlighting its value as an analytical method that complements experimental studies in molecular biology.

Kaori Fukuzawa · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.